This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris-Saclay. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Emeline Vernhes: Innovator in Nanoparticle Technology
Introduction
Emeline Vernhes is a notable inventor based in Toulouse, France. She has made significant contributions to the field of nanoparticle technology, particularly in the production and functionalization of nanoparticles derived from phage T5. Her work has important therapeutic implications, showcasing her innovative spirit and dedication to advancing scientific knowledge.
Latest Patents
Emeline Vernhes holds a patent titled "Production and Functionalization of Nanoparticles Derived from Phage T5 and Therapeutic Uses." This patent highlights her pioneering research in the development of nanoparticles, which can be utilized in various therapeutic applications. She has successfully secured 1 patent that reflects her expertise and innovative approach in this specialized area.
Career Highlights
Throughout her career, Emeline has worked with prestigious institutions such as Université Paris-Saclay and the Centre National de la Recherche Scientifique. These affiliations have provided her with a robust platform to conduct her research and collaborate with other experts in the field. Her work has been instrumental in pushing the boundaries of what is possible in nanoparticle technology.
Collaborations
Emeline has collaborated with esteemed colleagues, including Karim Benihoud and Pascale Boulanger. These partnerships have enriched her research and contributed to the advancement of her projects.
Conclusion
Emeline Vernhes is a remarkable inventor whose work in nanoparticle technology is paving the way for future innovations in therapeutic applications. Her dedication to research and collaboration exemplifies the spirit of innovation in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile